Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

20 nov. 2025 16h05 HE | Source: CapsoVision

CapsoVision to Participate in the Benchmark 14th Annual Discovery Investor Conference

CapsoVision to Participate in the Benchmark 14th Annual Discovery Investor Conference
13 nov. 2025 16h05 HE | Source: CapsoVision

CapsoVision Reports Third Quarter 2025 Financial Results

SARATOGA, Calif., Nov. 13, 2025 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy...
10 nov. 2025 16h05 HE | Source: CapsoVision

CapsoVision Submits Breakthrough Device Designation Application to FDA for Pancreatic Cancer Screening Capsule

SARATOGA, Calif., Nov. 10, 2025 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy...
03 nov. 2025 08h00 HE | Source: CapsoVision

CapsoVision Appoints David Garcia as Senior Vice President of Finance

SARATOGA, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy...
30 oct. 2025 16h05 HE | Source: CapsoVision

CapsoVision to Release Third Quarter 2025 Financial Results on Thursday, November 13, 2025

SARATOGA, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy...
25 sept. 2025 16h05 HE | Source: CapsoVision

CapsoVision to Participate in the 4th Annual ROTH Healthcare Opportunities Conference

SARATOGA, Calif., Sept. 25, 2025 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy...
14 août 2025 16h05 HE | Source: CapsoVision

CapsoVision Reports Second Quarter 2025 Financial Results

SARATOGA, Calif., Aug. 14, 2025 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy...
31 juil. 2025 16h05 HE | Source: CapsoVision

CapsoVision to Release Second Quarter 2025 Financial Results on Thursday, August 14, 2025

- Conference Call Scheduled for Thursday, August 14, 2025 at 4:30 pm ET - SARATOGA, Calif., July 31, 2025 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology...
03 juil. 2025 11h50 HE | Source: CapsoVision

CapsoVision Announces Closing of Initial Public Offering

SARATOGA, Calif., July 03, 2025 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company that develops advanced imaging and artificial intelligence (“AI”)...
01 juil. 2025 21h08 HE | Source: CapsoVision

CapsoVision Announces Pricing of Initial Public Offering

SARATOGA, Calif., July 01, 2025 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company that develops advanced imaging and artificial intelligence (“AI”)...